Bishal Gyawali/scri.queensu.ca
Feb 1, 2025, 08:37
Bishal Gyawali about the Destiny Breast 06 trial at ESMO24
Bishal Gyawali, Associate Professor at Queen’s University, Kingston, shared a post on LinkedIn:
“Destiny Breast 06 trial is making news again after the FDA approval. These were my thoughts about that trial immediately after it was presented at ESMO24. Check it out. Starts at 5:54.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 16:47
Sep 7, 2025, 16:30
Sep 7, 2025, 16:25